Divi's Laboratories
Mr. Nimmagadda is the Executive Director of Divi’s Laboratories Ltd and has been with Divi’s for the past 25 years. In his role, he oversees all functions of Strategic planning, Sales and Marketing, Custom Manufacturing, Contract research and Nutraceutical ingredients development.
Prior to joining Divi’s, Mr. Nimmagadda had over 10 years of experience in the Pharmaceutical industry and was instrumental in enhancing business development for several pharma companies. He is a graduate in chemistry from Osmania University, India. He is also a Member of the American Chemical Society.
This person is not in any teams
This person is not in any offices
Divi's Laboratories
4 followers
Divi's Laboratories Limited is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and Intermediates. The Company's geographical segments include India (Sales to customers within India) and other countries (Sales to customers outside India). Its products include Generic APIs, Intermediates, Peptide Building Blocks and Carotenoids. It is also involved in developing alternate, non-infringing processes for APIs, for the inventors to manage late life cycle and generic drug manufacturers. The Company develops carotenoids, such as Apocarotenal, Betacarotene, Lycopene, Astaxanthin and Canthaxanthin. It manufactures tert-butoxycarbonyl (BOC), Fluorenylmethyloxycarbonyl (FMOC) and Carboxybenzyl (CBZ) protected amino acids. It manufactures ligands, such as binol and binap. The Company exports its products to European and the American countries. Its manufacturing and research and development facilities are located in the State of Andhra Pradesh and Telangana in India.